Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

Completed · Phase 2 · Has a placebo group

Conditions studied: Insulin, Exercise

In brief

To determine if physical activity engagement alters the dose-response profile and safety of administration of insulin into the intranasal mucosa.

Key facts

Study ID

NCT04292535

Run by

Michigan State University

People needed

116

Starts

2018-06-15

Expected to finish

2020-02-20

Last updated by the study team

2021-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must be over the age of 18..
• Participants must have normal or corrected-to-normal vision in order to complete the cognitive task.

You may not qualify if…

• Lack of consent.
• Presence of any major neurological health issues, brain trauma, or concussion with loss of consciousness assessed through a health history and demographics questionnaire.
• Type I or Type II Diabetes
• Self-reported pregnancy
• Currently has any type of inflammation or blockage of the nasal passageways (i.e. allergies or a cold affecting the sinuses).

Where it is running

• Department of Kinesiology — East Lansing, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.